Disparities in Preconception Health Indicators - Behavioral Risk Factor Surveillance System, 2013-2015, and Pregnancy Risk Assessment Monitoring System, 2013-2014

Cheryl Robbins, Sheree L Boulet, Isabel Morgan, Denise V D'Angelo, Lauren B Zapata, Brian Morrow, Andrea Sharma, Charlan D Kroelinger, Cheryl Robbins, Sheree L Boulet, Isabel Morgan, Denise V D'Angelo, Lauren B Zapata, Brian Morrow, Andrea Sharma, Charlan D Kroelinger

Abstract

Problem/condition: Preconception health is a broad term that encompasses the overall health of nonpregnant women during their reproductive years (defined here as aged 18-44 years). Improvement of both birth outcomes and the woman's health occurs when preconception health is optimized. Improving preconception health before and between pregnancies is critical for reducing maternal and infant mortality and pregnancy-related complications. The National Preconception Health and Health Care Initiative's Surveillance and Research work group suggests ten prioritized indicators that states can use to monitor programs or activities for improving the preconception health status of women of reproductive age. This report includes overall and stratified estimates for nine of these preconception health indicators.

Reporting period: 2013-2015.

Description of systems: Survey data from two surveillance systems are included in this report. The Behavioral Risk Factor Surveillance System (BRFSS) is an ongoing state-based, landline and cellular telephone survey of noninstitutionalized adults in the United States aged ≥18 years that is conducted by state and territorial health departments. BRFSS is the main source of self-reported data for states on health risk behaviors, chronic health conditions, and preventive health services primarily related to chronic disease in the United States. The Pregnancy Risk Assessment Monitoring System (PRAMS) is an ongoing U.S. state- and population-based surveillance system administered collaboratively by CDC and state health departments. PRAMS is designed to monitor selected maternal behaviors, conditions, and experiences that occur before, during, and shortly after pregnancy that are self-reported by women who recently delivered a live-born infant. This report summarizes BRFSS and PRAMS data on nine of 10 prioritized preconception health indicators (i.e., depression, diabetes, hypertension, current cigarette smoking, normal weight, recommended physical activity, recent unwanted pregnancy, prepregnancy multivitamin use, and postpartum use of a most or moderately effective contraceptive method) for which the most recent data are available. BRFSS data from all 50 states and the District of Columbia were used for six preconception health indicators: depression, diabetes (excluded if occurring only during pregnancy or if limited to borderline/prediabetes conditions), hypertension (excluded if occurring only during pregnancy or if limited to borderline/prehypertension conditions), current cigarette smoking, normal weight, and recommended physical activity. PRAMS data from 30 states, the District of Columbia, and New York City were used for three preconception health indicators: recent unwanted pregnancy, prepregnancy multivitamin use, and postpartum use of a most or moderately effective contraceptive method by women or their husbands or partners (i.e., male or female sterilization, hormonal implant, intrauterine device, injectable contraceptive, oral contraceptive, hormonal patch, or vaginal ring). Heavy alcohol use during the 3 months before pregnancy also was included in the prioritized set of 10 indicators, but PRAMS data for each reporting area are not available until 2016 for that indicator. Therefore, estimates for heavy alcohol use are not included in this report. All BRFSS preconception health estimates are based on 2014-2015 data except two (hypertension and recommended physical activity are based on 2013 and 2015 data). All PRAMS preconception health estimates rely on 2013-2014 data. Prevalence estimates of indicators are reported for women aged 18-44 years overall, by age group, race-ethnicity, health insurance status, and reporting area. Chi-square tests were conducted to assess differences in indicators by age group, race/ethnicity, and insurance status.

Results: During 2013-2015, prevalence estimates of indicators representing risk factors were generally highest and prevalence estimates of health-promoting indicators were generally lowest among older women (35-44 years), non-Hispanic black women, uninsured women, and those residing in southern states. For example, prevalence of ever having been told by a health care provider that they had a depressive disorder was highest among women aged 35-44 years (23.1%) and lowest among women aged 18-24 years (19.2%). Prevalence of postpartum use of a most or moderately effective method of contraception was lowest among women aged 35-44 years (50.6%) and highest among younger women aged 18-24 years (64.9%). Self-reported prepregnancy multivitamin use and getting recommended levels of physical activity were lowest among non-Hispanic black women (21.6% and 42.8%, respectively) and highest among non-Hispanic white women (37.8% and 53.8%, respectively). Recent unwanted pregnancy was lowest among non-Hispanic white women and highest among non-Hispanic black women (5.0% and 11.6%, respectively). All but three indicators (diabetes, hypertension, and use of a most or moderately effective contraceptive method) varied by insurance status; for instance, prevalence of current cigarette smoking was higher among uninsured women (21.0%) compared with insured women (16.1%), and prevalence of normal weight was lower among women who were uninsured (38.6%), compared with women who were insured (46.1%). By reporting area, the range of women reporting ever having been told by a health care provider that they had diabetes was 5.0% (Alabama) to 1.9% (Utah), and women reporting ever having been told by a health care provider that they had hypertension ranged from 19.2% (Mississippi) to 7.0% (Minnesota).

Interpretation: Preconception health risk factors and health-promoting indicators varied by age group, race/ethnicity, insurance status, and reporting area. These disparities highlight subpopulations that might benefit most from interventions that improve preconception health.

Public health action: Eliminating disparities in preconception health can potentially reduce disparities in two of the leading causes of death in early and middle adulthood (i.e., heart disease and diabetes). Public health officials can use this information to provide a baseline against which to evaluate state efforts to improve preconception health.

References

    1. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2017.
    1. Cunningham TJ, Croft JB, Liu Y, Lu H, Eke PI, Giles WH. Racial disparities in age-specific mortality among blacks or African Americans—United States, 1999–2015. MMWR Morb Mortal Wkly Rep 2017;66:444–56 10.15585/mmwr.mm6617e1
    1. Chandra A, Copen CE, Stephen EH. Infertility and impaired fecundity in the United States, 1982–2010: data from the national survey of family growth. Hyattsville, MD: CDC, National Center for Health Statistics; 2013.
    1. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374:843–52 10.1056/NEJMsa1506575
    1. Barfield WD, Warner L. Preventing chronic disease in women of reproductive age: opportunities for health promotion and preventive services. Prev Chronic Dis 2012;9:E34.
    1. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 2004;27(Suppl 1):S76–8 10.2337/diacare.27.2007.S76
    1. Lapolla A, Dalfrà MG, Fedele D. Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract 2008;80:2–7 10.1016/j.diabres.2007.11.009
    1. Ankumah NA, Cantu J, Jauk V, et al.. Risk of adverse pregnancy outcomes in women with mild chronic hypertension before 20 weeks of gestation. Obstet Gynecol 2014;123:966–72 10.1097/AOG.0000000000000205
    1. Livingston JC, Maxwell BD, Sibai BM. Chronic hypertension in pregnancy. Minerva Ginecol 2003;55:1–13.
    1. Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General’s report: commemorating the 50th anniversary of the 1964 report of the advisory committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J Epidemiol 2014;179:403–12 10.1093/aje/kwt335
    1. American College of Obstetricians and Gynecologists. Opinion number 471: smoking cessation during pregnancy. Obstet Gynecol 2010;116:1241–4.
    1. American College of Obstetricians and Gynecologists. Opinion number 486: at-risk drinking and alcohol dependence: obstetric and gynecologic implications. Obstet Gynecol 2011;118:383–8.
    1. US Department of Health and Human Services. US Surgeon General releases advisory on alcohol use in pregnancy [Press release]. Washington, DC: US Department of Health and Human Services; 2005.
    1. United States Preventive Services Task Force. Folic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:626–31 10.7326/0003-4819-150-9-200905050-00009
    1. Guide to Community Preventive Services. Task force findings for excessive alcohol consumption. Atlanta, GA: Guide to Community Preventive Services; 2017.
    1. Jones TB, Bailey BA, Sokol RJ. Alcohol use in pregnancy: insights in screening and intervention for the clinician. Clin Obstet Gynecol 2013;56:114–23 .10.1097/GRF.0b013e31827957c0
    1. United States Preventive Services Task Force . Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004;140:554–6 10.7326/0003-4819-140-7-200404060-00016
    1. Fiore M, Jaén CR, Baker TB, et al.; Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. a U.S. Public Health Service report. Am J Prev Med 2008;35:158–76 .10.1016/j.amepre.2008.04.009
    1. Guide to Community Preventive Services. Tobacco use and secondhand smoke exposure: interventions to increase the unit price of tobacco products. Atlanta, GA: Guide to Community Preventive Services; 2017.
    1. Johnson K, Posner SF, Biermann J, et al. Recommendations to improve preconception health and health care—United States: a report of the CDC/ATSDR preconception care work group and the select panel on preconception care. MMWR Recomm Rep 2006;55(No. RR-6):
    1. American College of Obstetricians and Gynecologists. Opinion number 313: the importance of preconception care in the continuum of women’s health care. Obstet Gynecol 2005;106:665–6.
    1. Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: recommendations of CDC and the US Office of Population Affairs. MMWR Recomm Rep 2014;63(RR-4):1–54
    1. Jack BW, Atrash H, Coonrod DV, Moos MK, O’Donnell J, Johnson K. The clinical content of preconception care: an overview and preparation of this supplement. Am J Obstet Gynecol 2008;199(Suppl 2):S266–79 10.1016/j.ajog.2008.07.067
    1. D’Angelo D, Williams L, Morrow B, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant—Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2007;56(No. SS-10):
    1. Broussard DL, Sappenfield WB, Fussman C, Kroelinger CD, Grigorescu V. Core state preconception health indicators: a voluntary, multi-state selection process. Matern Child Health J 2011;15:158–68 10.1007/s10995-010-0575-x
    1. Robbins CL, Zapata LB, Farr SL, et al. Core state preconception health indicators—Pregnancy Risk Assessment Monitoring System and Behavioral Risk Factor Surveillance System, 2009. MMWR Surveill Summ 2014;63(No. SS-3).
    1. Robbins CL, D’Angelo D, Zapata L, et al. Preconception health indicators for public health surveillance. J Womens Health (Larchmt) 2018. In press.
    1. Blumenshine P, Egerter S, Barclay CJ, Cubbin C, Braveman PA. Socioeconomic disparities in adverse birth outcomes: a systematic review. Am J Prev Med 2010;39:263–72 10.1016/j.amepre.2010.05.012
    1. Kim TY, Dagher RK, Chen J. Racial/ethnic differences in unintended pregnancy: evidence from a national sample of US women. Am J Prev Med 2016;50:427–35 10.1016/j.amepre.2015.09.027
    1. Institute of Medicine. Clinical preventive services for women: closing the gaps. Washington, DC: The National Academies Press; 2011.
    1. CDC. Fact sheets—alcohol use and your health. Atlanta, GA: US Department of Health and Human Services, CDC; 2017.
    1. US Department of Health and Human Services. 2008 physical activity guidelines for Americans. Hyattsville, MD: US Department of Health and Human Services; 2008.
    1. Trussell J. Contraceptive efficacy. In: Hatcher R, Trussell J, Nelson AL, Cates W Jr, Stewart FH, Kowal D, eds. Contraceptive technology. New York, NY: Ardent Media; 2011:777–861.
    1. US Census Bureau. Geographic terms and concepts—census divisions and census regions. Washington, DC: US Census Bureau; 2015.
    1. CDC. A practitioner’s guide for advancing health equity: community strategies for preventing chronic disease. Atlanta, GA: US Department of Health and Human Services, CDC; 2013.
    1. Syndemics: health in context. Lancet 2017;389:881 10.1016/S0140-6736(17)30640-2
    1. Penman-Aguilar A, Bouye K, Liburd L. Strategies for reducing health disparities—selected CDC-sponsored interventions, United States, 2016. MMWR Suppl 2016;65(No. Suppl 1).
    1. Association of State and Territorial Health Officials. Increasing access to contraception. Arlington, VA: Association of State and Territorial Health Officials; 2017.

Source: PubMed

3
購読する